Overview

Lipoic Acid for Secondary Progressive Multiple Sclerosis (MS)

Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine if lipoic acid can protect the brain and slow disability in secondary progressive multiple sclerosis.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
VA Office of Research and Development
Collaborator:
Oregon Health and Science University
Treatments:
Thioctic Acid